Private equity firm SK Capital Partners will acquire the antioxidant and ultra-violet stabilizer businesses of Chemtura Corp. (NYSE: CHMT) for $200 million.
Chemtura supplies additives such as antioxidants, intermediates and inhibitors, polymer modifiers and UV stabilizers that customers use to improve the production and performance properties of polymers, rubbers and plastics.
SK Capital, based in New York and Boca Raton, Fla., focuses on the specialty materials, chemical and healthcare sectors. The firm is investing from its third fund, which has $500 million in committed capital.
Latham & Watkins LLP acted as SK Capital’s legal counsel.